Cost utility of drugs for multiple sclerosis. Methods used don't calculate true benefit.

Cost utility of drugs for multiple sclerosis. Methods used don't calculate true benefit.

Mostrar outras versões (1)

Detalhes bibliográficos
Principais autores:	Richards, R, Burls, A, Payne, N
Formato:	Journal article
Idioma:	English
Publicado em:	2000

Cost utility of drugs for multiple sclerosis. Methods used don't calculate true benefit.

Cost utility of drugs for multiple sclerosis. Methods used don't calculate true benefit. por Richards, R, Burls, A, Payne, N

Publicado em 2000

Journal article